Regeneron (REGN) Misses Q1 EPS by 26c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $797.99 --0%
Financial Fact:
Net product sales: 857.47M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net product sales: 857.47M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $8.22, $0.26 worse than the analyst estimate of $8.48. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $3.24 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Arcos Dorados (ARCO) Tops Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
